MSMasako Shimamura

Masako Shimamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Masako Shimamura has a total of 85 co-authors. Here are the top co-authors by number of shared publications:

  • Ravi Dhital

    Center for Vaccines and Immunity, Abigail Wexner Research Institute, Nationwide Children’s Hospital , Columbus, OH

    4 shared publications
  • Qiang Zeng

    Center for Cardiovascular Research, The Abigail Research Institute, Nationwide Children’s Hospital, Columbus, Ohio 43205, USA

    3 shared publications
  • Amy Leber

    Department of Pathology Nationwide Children's Hospital, Microbiology and Laboratory Medicine Columbus Ohio USA

    2 shared publications
  • Bo Chen

    Division of Cardiothoracic Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL

    2 shared publications
  • Juhyeong Kim

    Center for Vaccines and Immunity, The Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus Ohio USA

    2 shared publications
  • Kaitlyn Flint

    Center for Vaccines and Immunity, The Abigail Wexner Research Institute at Nationwide Children’s Hospital , Columbus OH

    2 shared publications

Latest Publications

  • Transplant mice with acute viral infection develop functionally distinct antigen-specific PD-1− and PD-1+ CXCR5+CD8+ T-cell effectors

    by Jason M Zimmerer, Sydney Castellanos, Hatem Aldhahi, Mahmoud Abdel-Rasoul, Ravi Dhital, Masako Shimamura, Ginny L Bumgardner

    We investigated the development, antigen specificity, and effector functions of PD-1− and PD-1+ CXCR5+CD8+ T-cell subsets in transplant mice with acute murine cytomegalovirus (MCMV) infection. MCMV-primed (MCMV-Tet+) or alloprimed (MCMV-Tet−) CD8+ T cells from C57BL/6 mice were flow-sorted and adoptively transferred into MCMV-infected CD8 knockout transplant recipients. Alloantibody titer, quantities of primed germinal center (GC) B cells, anti-MCMV antibody titer, and MCMV viral titer were assessed on day 14 posttransplant. Following adoptive transfer (AT), alloprimed PD-1− (but not PD-1+) CXCR5+CD8+ T cells mediated suppression of alloantibody (1.8-fold) and reduced the quantity of alloprimed (alloTet+) GC B cells (2.4-fold) and CD4+ TFH cells (2.8-fold) but did not impact anti-MCMV antibody levels, the quantity of MCMV-primed GC B cells or CD4+ TFH cells, or MCMV viral titer. Conversely, AT of MCMV-primed (MCMV-Tet+) CXCR5+PD-1−CD8+ T cells into MCMV-infected transplant mice suppressed anti-MCMV antibody (1.7-fold) and reduced the quantity of MCMV-primed GC B cells (3.3-fold) and MCMV-Tet+ CD4+ TFH cells (2.5-fold) but did not impact alloantibody levels, the quantity of alloprimed GC B cells or CD4+ TFH cells, nor MCMV viral titer. Antibody suppression by antigen-specific CXCR5+PD-1−CD8+ T cells is associated with cytotoxic killing of antigen-primed GC B cells in vitro and reduction of antigen-primed GC B-cell quantity in vivo. In contrast, AT of MCMV-primed CXCR5+PD-1+CD8+ T cells reduced MCMV viral titer without influencing anti-MCMV antibody or alloantibody levels. These data indicate that PD-1− and PD-1+ subsets of CXCR5+CD8+ T cells, which emerge acutely after viral infection or transplant, mediate distinct antigen-specific effector functions.

  • Open Access

    Fatal Congenital Toxoplasmosis with Progressive Liver Failure and Genomic Characterization of a Novel Isolate from the United States

    by Katsuaki Kojima, Indu Varier, Rouba Sayegh, Masako Shimamura, Bimal P. Chaudhari, Anas Bernieh, Matthew J. Schulz, Peter White, James Fitch, Alexandra K. Medoro, et al.

    Congenital toxoplasmosis presents with a wide clinical spectrum, ranging from asymptomatic infection to severe disease with multi-organ failure. We report a rare fatal case of disseminated congenital toxoplasmosis in a human neonate. The infant initially had thrombocytopenia and mild hepatitis, which rapidly progressed to fulminant liver failure. Despite initiation of standard therapy with pyrimethamine, sulfadiazine, and folinic acid on postnatal day 25, the infant died two days later. Autopsy revealed widespread involvement of the liver, spleen, brain, heart, lungs, urinary bladder, and skeletal muscle. To further characterize the infection, genomic sequencing of the isolate (TgHsUS2) was performed, which placed it within clade C (Haplogroup 9) and closely related to reference strains P89 and TgCatBr3. Variant analysis showed type III-like alleles in ROP18, ROP16, and GRA15. These alleles are known to modulate host immunity and may have influenced disease severity in this case. This report highlights the need for rapid recognition and targeted therapy as well as how strain genomics can inform disease mechanisms. Prevention through prenatal screening and maternal treatment during pregnancy may reduce infant mortality.

  • Open Access

    Successful treatment of macrolide-resistant Mycobacterium abscessus infection using multi-drug regimens including dual β-lactams and phage therapy: case reports in two children

    by Masako Shimamura, Bradford Becken, Jessica Tansmore, Madison Cristinziano, Lawrence Abad, Rebekah M. Dedrick, Deborah Jacobs-Sera, Graham F. Hatfull, Robert A. Bonomo, Khalid M. Dousa

    Background: Mycobacterium abscessus ( M. abscessus ) infections are poorly responsive to antibiotics, with lower rates of clinical and microbiological clearance for macrolide-resistant isolates compared to macrolide-susceptible strains. Successful treatment of macrolide-resistant M. abscessus infection has not been reported for children. Case Summary: Here we report two children with macrolide-resistant M. abscessus infections who achieved clinical remission and microbiologic clearance using multi-drug treatment regimens including clofazimine, bedaquiline, linezolid or eravacycline, dual β-lactam therapy with meropenem and amoxicillin, and, in one case, phage therapy. Conclusion: Successful treatment of macrolide-resistant M. abscessus infections in children can be achieved using multi-drug regimens including novel dual β-lactam combinations and phage therapy. Dose adjustment with therapeutic drug monitoring can ameliorate some drug-induced toxicities in children.


  • Open Access

    Agreement Between Dried Blood Spot and Plasma PCR in Infants With Congenital Cytomegalovirus Infection

    by Masako Shimamura, Juhyeong Kim, Alexandra K. Medoro, Kaitlyn Flint, Irina Kaptsan, Huanyu Wang, Traci Pifer, Rachelle Harris, José Cuartas, Amy Leber, et al.

    Congenital cytomegalovirus (cCMV) infection is diagnosed by positive urine or saliva testing within 21 days after birth. Beyond this age, newborn dried blood spot (DBS) PCR can retrospectively diagnose cCMV infection but has lower sensitivity than urine or saliva PCR testing. The DBS PCR may be negative due to the absence of blood DNAemia at birth or to the technical limit of detection for DBS PCR. The objective of this study was to distinguish these two possibilities by determining agreement between DBS and plasma CMV PCR tests among cCMV‐infected infants. This single center retrospective cohort study evaluated 70 cCMV‐infected infants diagnosed by a positive urine CMV PCR, who had a CMV DBS at birth and a plasma PCR test within 31 days after birth. Clinical characteristics and viral loads were compared between groups according to paired DBS and plasma PCR results. Test agreement was calculated using Cohen's kappa coefficient. The DBS PCR sensitivity was 71% compared to urine PCR. Of the 70 subjects, 49 (70%) subjects were DBS+ /plasma+ , 1 (1.4%) were DBS+ /plasma−, 14 (20%) were DBS−/plasma+ , and 6 (9%) were DBS−/plasma−. Agreement between the tests was fair (κ = 0.348, 95% CI 0.115‐0.581). Of the 20 subjects with DBS− tests, 6 (30%) had undetectable plasma DNAemia. Of the infants with DBS−/plasma+ PCR, plasma viral loads were significantly lower than infants with DBS+ /plasma+ PCR testing. Nearly a third of cCMV infected infants may be missed by DBS testing due to both biological and technical limitations of this method.


  • Virus-specific Th17 Cells Are Induced by Human Cytomegalovirus after Renal Transplantation

    by Ravi Dhital, Kaitlyn Flint, Irina Kaptsan, Shweta Hegde, Reem Daloul, Masako Shimamura

    CMV infection and Th17 cells are independently associated with increased risk for late allograft loss after renal transplantation. Although CMV-specific Th17 cells are detectable in animal models and nontransplant clinical populations, evidence linking CMV and Th17 cells after renal transplantation remains unclear. This prospective observational study evaluated a cohort of renal transplant recipients during 12 mo posttransplant to assess the presence of CMV-specific Th17 cells in peripheral blood and their relationship to pretransplant CMV serostatus and CMV DNAemia. CMV-specific Th17 cells were identified among CMV serostatus donor (D)+ and/or recipient (R)+ recipients and expanded during both primary (D+/R−) and reactivated (D+/R+, D−/R+) CMV DNAemia. A subset of CMV-specific Th17 cells coexpressed IFN-γ, indicating a Th1/17 phenotype. These Th17 and Th1/17 cells expressed CCR6, CCR5, activation and terminal differentiation markers (CD95, OX40, HLA-DR, CD57), and a central/effector memory phenotype. CMV-specific Th1/17 cells expressed activating/inhibitory receptors (CD57, 4-1BB, CD160, CTLA-4, PD-1) at higher frequencies than Th17 cells. In contrast, staphylococcal enterotoxin B–induced Th17 cells did not expand during CMV DNAemia, did not differ between CMV serostatus groups over time, expressed CCR6, predominantly coexpressed TNF-α, and had lower expression of activating and inhibitory receptors than pp65-specific Th17 and Th1/17 cells. These data show that CMV-specific Th17 cells expand during episodes of CMV DNAemia among renal transplant recipients, and that these virus-specific Th17 and Th1/17 cells have distinct phenotypes from global circulating Th(1)/17 cells. These results suggest a potential proinflammatory pathway by which CMV-induced Th17 cells may contribute to allograft injury, increasing risk for late allograft loss.


  • Open Access

    T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection

    by Alexandra K. Medoro, Ravi Dhital, Pablo J. Sánchez, Kaitlyn Flint, Brianna Graber, Traci Pifer, Rachelle Crisan, William C. Ray, Christopher C. Phelps, Jonathan R. Honegger, et al.

    BACKGROUND: Congenital cytomegalovirus (cCMV) infection can cause developmental impairment and sensorineural hearing loss (SNHL). To determine the relationship between immune responses to cCMV infection and neurologic sequelae, T cell responses were compared for their connection to clinical symptoms at birth and neurodevelopmental outcomes. METHODS: Thirty cCMV-infected and 15 uninfected infants were enrolled in a single-center prospective observational case-control study. T cell pp65-specific cytokine responses; CD57, CD28, and PD-1 expression; and memory subsets were compared. RESULTS: Infected neonates (73% symptomatic at birth) lacked pp65-specific cytokine-secreting T cells, with elevated frequencies of CD57 + , CD28 – , and PD-1 + CD8 + T cells and effector memory subsets. Though frequencies overlapped between cCMV symptom groups, asymptomatic infants had higher frequencies of CD57 + PD-1 + CD8 + T cells. Neonates with subsequent developmental delay lacked detectable CMV-specific T cell responses, with patterns resembling those of uninfected infants. Two children with progressive SNHL had high frequencies of PD-1 + CD8 + T cells over the first year compared with children without progressive SNHL. CONCLUSION: Similar to published reports, neonatal viral antigen–specific cytokine-secreting T cell responses were not detected, but overall patterns indicate that globally differentiated memory CD8 + T cell populations were induced by cCMV infection, with higher frequencies of terminally differentiated PD-1 + CD8 + T cells potentially associated with asymptomatic infection. In this cohort, a lack of in utero T cell differentiation was associated with developmental delay, and high frequencies of PD-1 + CD8 + T cells persisted only in children with progressive SNHL. Further work is needed to define the specificity of these T cells and their mechanistic connection to these outcomes. FUNDING: This study was funded through an intramural research award at Nationwide Children’s Hospital, the Pediatric Infectious Disease Society Fellowship Award funded by Stanley and Susan Plotkin and Sanofi Pasteur, the Abigail Wexner Research Institute at Nationwide Children’s Hospital, and the Pichichero Family Foundation Vaccines for Children Initiative Research Award from the Pediatric Infectious Diseases Society Foundation.


  • Open Access

    1099. CMV PCR Agreement between Blood and Dried Blood Spots in Infants with Congenital Cytomegalovirus Infection

    by Juhyeong Kim, Huanyu Wang, Alexandra Katherine Medoro, Traci Pifer, Rachelle Crisan, Amy Leber, Kaitlyn Flint, Sebastian Powell, Pablo J Sanchez, Masako Shimamura

    Dried blood spot (DBS) PCR sensitivity for congenital cytomegalovirus (cCMV) screening ranges from 34% to 86%, but it is unclear whether a negative DBS PCR reflects an absence of CMV DNAemia or a technical limitation in viral detection by DBS PCR. The objective of this study was to determine the agreement between CMV DNA PCR tests in plasma and DBS among cCMV infected infants. This single center retrospective cohort study evaluated infants diagnosed with cCMV infection by urine CMV PCR at age ≤ 21 days due to clinical symptoms, failed newborn hearing screen, or NICU admission screening. Subjects with a plasma CMV PCR test performed within the first month after birth and a newborn CMV DBS PCR test were included in the study. Agreement between the plasma and DBS PCR tests was calculated using Cohen’s kappa coefficient. Clinical characteristics and viral loads were compared between groups with concordant and discordant DBS and plasma PCR tests using the Kruskal-Wallis or Mann-Whitney U test. In this predominantly symptomatic cohort, DBS PCR identified the majority (71%) of infants with cCMV infection. A negative DBS PCR was associated with either low-level plasma CMV DNAemia that was seen in 20% of cCMV infected infants, or no plasma DNAemia in 9% of infants. These findings may impact the use of DBS as a screening test for cCMV infection. Alexandra Katherine Medoro, MD, Merck: Grant/Research Support Amy Leber, PhD, Biomeriux: Grant/Research Support|BioRad: Advisor/Consultant|Cephied: Grant/Research Support|Diasorin: Grant/Research Support

  • Open Access

    Th1/17 Cells Infiltrate Murine Cytomegalovirus-Infected Renal Allografts via Virus-Induced CCL20 and Promote Th1 Cells through IL-17A

    by Ravi Dhital, Shashi Anand, Qiang Zeng, Victoria M. Velazquez, Srinivasa R. Boddeda, James R. Fitch, Ranjana W. Minz, Mukut Minz, Ashish Sharma, Rachel Cianciolo, et al.

    Cytomegalovirus (CMV) infection is associated with renal allograft failure by unknown mechanisms. In a murine renal transplant model, murine CMV (MCMV) induces intragraft infiltration of Th17 cells co-expressing Th1 cytokines, IFN-γ and TNF-α, but only a minority of intragraft Th17 cells are specific for MCMV antigens. Instead, MCMV promotes viral antigen-independent Th17 cell recruitment via CCL20-CCR6 and CXCL10-CXCR3 interactions. Th17 cells correlate directly with Th1 cell frequencies and inversely with Tregs in MCMV infected grafts. Pharmacologic inhibition of IL-17A reduces intragraft Th17 cells and neutrophils, increases Tregs, and reduces total but not MCMV-specific Th1 cells. Among a clinical renal transplant cohort with acute rejection, patients with CMV DNAemia had significantly higher serum IL-17A quantities compared to those without CMV DNAemia. Together, these findings indicate that CMV infection upregulates Th17 cell activity during acute rejection and suggests that inhibition of IL-17A may ameliorate CMV-associated allograft injury without impairing antiviral Th1 cells.


  • Murine Cytomegalovirus–induced Complement-fixing Antibodies Deposit in Murine Renal Allografts During Acute Rejection

    by Ute Drn Saunders, Mao Li, Srinivasa R. Boddeda, Sonya Ba Maher, Jessica Ba Ghere, Irina Mcr Kaptsan, Ravi Dhital, Victoria Velazquez, Lingling Guo, Bo Chen, et al.

    Background.: Human cytomegalovirus (CMV) infection is associated with renal allograft dysfunction and loss, particularly in combination with acute rejection. Emerging literature suggests that non-HLA antibodies may contribute to antibody-mediated rejection, but pathogen-induced antibodies have not been investigated in this context. This study examines the presence of CMV-induced antibodies in murine CMV (MCMV)–infected renal allografts during acute rejection. Methods.: Intragraft immunoglobulin G (IgG) and complement C3 immunostaining were compared among allogeneic MCMV D−/R−, D+/R−, and D+/R+ renal transplants. Intragraft antibody deposition was examined in B cell–deficient recipients treated with MCMV immune sera. Antibody binding and complement-dependent cytotoxicity (CDC) of D−/R− and D+/R+ sera against infected renal tubular epithelial cells (TECs) were measured in vitro. IgG immunostaining was performed in D+/R+ allografts and native kidneys and in D+/R− allografts treated with ganciclovir to inhibit viral replication. Results.: D+/R− and D+/R+ transplants had more abundant IgG and C3 deposition compared with D−/R− recipients. Greater IgG deposition was associated with more severe allograft injury in B cell–deficient recipients treated with MCMV immune sera compared with nonimmune sera. D+/R+ sera induced greater CDC of infected TECs compared with D−/R− sera. Native kidneys had lower IgG deposition compared with allografts, despite similar organ viral loads. Ganciclovir-treated allografts had reduced IgG deposition compared with untreated allografts. Conclusions.: In this murine model, complement-fixing antibodies can deposit into MCMV-infected renal allografts, are associated with allograft damage, and can induce CDC of MCMV-infected renal TECs. The allogeneic response and viral replication may also contribute to intragraft antibody deposition.


  • Open Access

    NK cell and Th17 responses are differentially induced in murine cytomegalovirus infected renal allografts and vary according to recipient virus dose and strain

    by Mao Li, Srinivasa Rao Boddeda, Bo Chen, Qiang Zeng, Trenton R. Schoeb, Victoria M. Velazquez, Masako Shimamura